These resources and guidelines are intended to aid clinicians in their clinical decision-making and management of patients, provide information on evidence-based treatment, and provide members with the most up-to-date best practices and information on addiction medicine.
ASAM developed the National Practice Guideline to provide information on evidence-based treatment of opioid use disorder and is the first to address all of the FDA-approved medications available to treat addiction involving opioid use and opioid overdose in a single document.
The Clinical Practice Guideline on the Management of Stimulant Use Disorder was developed to provide information on evidence-based strategies and standards of care for the prevention and treatment of stimulant use disorders (StUD), stimulant intoxication, and stimulant withdrawal. (Public Comment Period)
The ASAM Guideline on Alcohol Withdrawal Management is intended to aid clinicians in their clinical decision-making and management of patients experiencing alcohol withdrawal syndrome.
ASAM developed the Appropriate Use of Drug Testing in Clinical Addiction Medicine document to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment, and promotion of recovery for patients with, or at risk for, addiction.
Designed to support jails and communities in providing effective health care for adults (18 years of age and older) who are sentenced or awaiting sentencing to jail, awaiting court action on a current charge, or being held in custody for other reasons (e.g., violation of terms of probation or parole) and are at risk for or experiencing substance withdrawal.
These resources will help members ensure they are delivering the best quality of care to their patients.